Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+717K
-
Total reported value, excl. options
-
$694M
-
Value change
-
+$15.8M
-
Put/Call ratio
-
1.93
-
Number of buys
-
73
-
Number of sells
-
-59
-
Price
-
$23.85
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q2 2018
162 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q2 2018.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 31.6M outstanding shares and own 92.28% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.81M shares), MACQUARIE GROUP LTD (2.59M shares), BlackRock Inc. (2.25M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.21M shares), Rock Springs Capital Management LP (1.65M shares), FRANKLIN RESOURCES INC (1.41M shares), VANGUARD GROUP INC (1.26M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.23M shares), Sectoral Asset Management Inc (1.11M shares), and MORGAN STANLEY (880K shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.